Related Experiment Video
Updated: Feb 16, 2026

Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
Published on: September 17, 2021
TWEAK/Fn14 promotes oxidative stress through AMPK/PGC‑1α/MnSOD signaling pathway in endothelial cells
Hengdao Liu1, Hui Peng1, Hong Xiang1
1Center for Experimental Medical Research, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Abstract:
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) contributes to dysfunction of endothelial cells via its receptor, Fn14. However, its role in the production of reactive oxygen species (ROS), particularly mitochondrial ROS (mtROS) and the subsequent decrease in nitric oxide (NO) in endothelial cells remains unclear. In this study, the effect of TWEAK/Fn14 on generation of ROS, mtROS and NO in endothelial cells and its potential mechanism was investigated. Human umbilical vein endothelial cells (HUVECs) were treated with TWEAK with Fn14 small interfering (si)RNA or negative control RNA. It was demonstrated that TWEAK induced the production of ROS and mtROS in HUVECs, which were detected by fluorescent microscope, and flow cytometry. In addition, TWEAK decreased the generation of NO as indicated using the Nitric Oxide Assay kit. Furthermore, TWEAK aggravated mtDNA damage as measured by quantitative polymerase chain reaction analysis. Inhibition of Fn14 by Fn14 siRNA decreased TWEAK‑induced ROS and mtROS production, as well as mtDNA damage, while it increased the production of NO in endothelial cells. In addition, TWEAK inhibited the expression of active AMP‑activated protein kinase (AMPK) and its downstream protein peroxisome proliferator‑activated receptor‑γ coactivator-1α (PGC‑1α) and manganese superoxide dismutase (MnSOD). Notably, Fn14 siRNA enhanced the expression of the aforementioned proteins. Taken together, TWEAK/Fn14 contributes to endothelial dysfunction through modulation of ROS and mtROS. In addition, the underlying mechanism is implicated in the AMPK/PGC‑1α/MnSOD signaling pathway.
Insights
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) increases reactive oxygen species (ROS) and mitochondrial ROS (mtROS) in endothelial cells, impairing nitric oxide (NO) production. This dysfunction involves the TWEAK/Fn14 pathway and the AMPK/PGC-1α/MnSOD signaling cascade.
Area of Science:
- Endothelial cell biology
- Molecular mechanisms of cell dysfunction
- Oxidative stress research
Background:
- Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is known to cause endothelial cell dysfunction via its receptor, Fn14.
- The specific role of TWEAK/Fn14 in regulating reactive oxygen species (ROS), particularly mitochondrial ROS (mtROS), and nitric oxide (NO) production in endothelial cells is not fully understood.
Purpose of the Study:
- To investigate the impact of the TWEAK/Fn14 pathway on ROS, mtROS, and NO generation in human umbilical vein endothelial cells (HUVECs).
- To elucidate the underlying molecular mechanisms, including the involvement of the AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)/manganese superoxide dismutase (MnSOD) signaling pathway.
Main Methods:
- Human umbilical vein endothelial cells (HUVECs) were treated with TWEAK and Fn14 small interfering (si)RNA or control RNA.
- ROS and mtROS production were assessed using fluorescent microscopy and flow cytometry.
- Nitric Oxide (NO) levels were measured using a Nitric Oxide Assay kit.
- Mitochondrial DNA (mtDNA) damage was quantified via polymerase chain reaction (PCR).
- Protein expression levels of active AMPK, PGC-1α, and MnSOD were analyzed.
Main Results:
- TWEAK significantly increased ROS and mtROS production and aggravated mtDNA damage in HUVECs.
- TWEAK treatment led to a decrease in NO generation.
- Inhibition of Fn14 using siRNA counteracted TWEAK-induced ROS and mtROS production and mtDNA damage, while restoring NO levels.
- TWEAK inhibited the expression of active AMPK, PGC-1α, and MnSOD; Fn14 siRNA reversed these inhibitory effects.
Conclusions:
- The TWEAK/Fn14 pathway contributes to endothelial dysfunction by modulating ROS and mtROS production.
- The underlying mechanism involves the disruption of the AMPK/PGC-1α/MnSOD signaling pathway.
- Targeting the TWEAK/Fn14 interaction may offer a therapeutic strategy for endothelial dysfunction associated with oxidative stress.
Related Concept Videos
Nitric Oxide Signaling Pathway
Regulation of the Unfolded Protein Response

